Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT04812548 |
Title | A Study of Sabatolimab in Combination With Azacitidine and Venetoclax in High or Very High Risk MDS Participants (STIMULUS-MDS3) |
Acronym | STIMULUS-MDS3 |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Novartis Pharmaceuticals |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | ITA | HUN | GRC | FRA | ESP | DEU | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Novartis Investigative Site | Brasschaat | 2930 | Belgium | Details | ||
Novartis Investigative Site | Marseille | 13273 | France | Details | ||
Novartis Investigative Site | Nice | 06202 | France | Details | ||
Novartis Investigative Site | Duesseldorf | 40479 | Germany | Details | ||
Novartis Investigative Site | Stuttgart | 70376 | Germany | Details | ||
Novartis Investigative Site | Alexandroupolis | Evros | 681 00 | Greece | Details | |
Novartis Investigative Site | Patras | 265 00 | Greece | Details | ||
Novartis Investigative Site | Nyiregyhaza | 4400 | Hungary | Details | ||
Novartis Investigative Site | Genova | GE | 16132 | Italy | Details | |
Novartis Investigative Site | Barcelona | Catalunya | 08036 | Spain | Details |